Glutaric aciduria type I (GA-I; synonym, glutaric acidemia type I) is a rare inherited metabolic
disease caused by deficiency of glutaryl-CoA dehydrogenase located in the catabolic …

Purpose Glutaric aciduria type 1 (GA1), a rare inherited neurometabolic disorder, results in
a complex movement disorder (MD) with predominant dystonia if untreated. Implementation …

In glutaric aciduria type I, an autosomal recessive disease of mitochondrial lysine,
hydroxylysine and tryptophan catabolism, striatal lesions are characteristically induced by acute …

Organic acidurias (synonym, organic acid disorders, OADs) are a heterogenous group of
inherited metabolic diseases delineated with the implementation of gas chromatography/mass …

Glutaryl-CoA dehydrogenase (GCDH) deficiency is a rare neurometabolic disorder that is
considered treatable if patients are identified before the onset of acute encephalopathic crises. …

Objective Untreated individuals with glutaric aciduria type 1 (GA1) commonly present with a
complex, predominantly dystonic movement disorder (MD) following acute or insidious onset …

Glutaric aciduria type 1 is a rare inherited neurometabolic disorder of lysine metabolism
caused by pathogenic gene variations in GCDH (cytogenic location: 19p13.13), resulting in …

BACKGROUND: Although extended newborn screening (NBS) programs have been introduced
more than 20 years ago, their impact on the long-term clinical outcome of individuals …

Aim To explore the clinical presentation, course, treatment and impact of early treatment in
patients with remethylation disorders from the European Network and Registry for …

Background Without neonatal initiation of treatment, 80–90% of patients with glutaric aciduria
type 1 (GA1) develop striatal injury during the first six years of life resulting in a complex, …